View Press Releases

Creative Proteomics Unleashes the Exosome Untargeted Metabolomics Service

November 15, 2023

Creative Proteomics, the globally recognized proteomics, metabolomics, and multi-omics service provider, is delighted to introduce its exosome untargeted metabolomics services—a premier-stage offering in their broad catalogue services.


Exosomes are tiny extracellular vesicles, hosting a diverse array of molecules including proteins, RNAs, and metabolites. With a diameter ranging between 30 to 150 nm, they interact with recipient cells to modify their functionalities, thus playing an integral role in various biological processes. Despite their miniature size, exosomes carry far-reaching implications for understanding major pathological conditions such as cancer, cardiovascular, and neurodegenerative diseases.


Combining the exponential potential of exosomes with the unbiased analysis capability of untargeted metabolomics yields a robust method for simultaneously detecting and quantifying thousands of metabolites. This data-rich approach offers a high-resolution snapshot of metabolic status, propelling advancements in clinical diagnostics and therapeutics.


Creative Proteomics' Exosome Untargeted Metabolomics service merges these potentials, delivering a comprehensive analysis of metabolic alterations in specific physiological and pathological conditions. Utilizing high-performance liquid chromatography coupled with high-resolution mass spectrometry (HPLC-HRMS), this cutting-edge technology provides unprecedented resolution in characterizing exosomal metabolites, presenting a detailed view of exosomal metabolic profiles.


With a focus on untargeted high-throughput metabolomics, Creative Proteomics stands out in deciphering metabolite changes in exosomes linked to various diseases. This service not only paves the way for new diagnostic markers and therapies but also serves pharmaceutical firms, research institutions, and biotechnology companies, fostering advancements in metabolomics research.

With this advanced and high-throughput method, it is no longer a far-fetched task to chart the previously invisible exosomal metabolome and tease out the meaningful information contained in its complexity. Assisting scientists to navigate through this labyrinth of possibilities, Creative Proteomics is not just a testing service provider, but a gateway to innovation and revolution in the field of metabolomics and exosome study.


The Chief Scientist of Creative Proteomics expressed her enthusiasm for the newly launched service, stating, “In conclusion, our service promises a robust and precise method to monitor real-time dynamic changes of numerous metabolites. It provides an unprecedented window into the intricate world of metabolomics, propelling the scientific community closer to breakthrough understandings of various pathological states. As Creative Proteomics continues to pioneer forward, it empowers researchers to unravel the depths of the exosome world, demystifying the mysteries of life one exosome at a time.”


About Creative Proteomics

Creative Proteomics is a reputable provider of proteomics and metabolomics services, offering a comprehensive suite of solutions to researchers worldwide. The company is committed to delivering high-quality services and enabling scientists to advance their research in proteomics, genomics, metabolomics, and bioinformatics.



Address: Shirley, NY 11967, USA